Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense gemcitabine and cisplatin in muscle-invasive bladder cancer
NCT01589094Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2012
- Primary completion
- Aug 2018
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, Cisplatin micelle injection (HA132) in bladder cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Apr 2012; status: completed.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01589094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01589094.